Natural Beauty Bio-Technology (HKSE:00157) Risk Assessment

View and export this data going back to 2002. Start your Free Trial

What is Natural Beauty Bio-Technology Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Natural Beauty Bio-Technology is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of Natural Beauty Bio-Technology's Risk Assessment

For the Household & Personal Products subindustry, Natural Beauty Bio-Technology's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Natural Beauty Bio-Technology's Risk Assessment Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Natural Beauty Bio-Technology's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Natural Beauty Bio-Technology's Risk Assessment falls into.

Natural Beauty Bio-Technology (HKSE:00157) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Natural Beauty Bio-Technology Risk Assessment Related Terms

Thank you for viewing the detailed overview of Natural Beauty Bio-Technology's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Natural Beauty Bio-Technology (HKSE:00157) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Natural Beauty Bio-Technology Ltd (HKSE:00157) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

NBBTF:USA

Address

348 Kwun Tong Road, 5th Floor, Manulife Place, Kowloon, Hong Kong, HKG

Website

https://www.nblife.com

Natural Beauty Bio-Technology Ltd operates as an investment holding company. It is engaged in the manufacturing and selling of skincare, beauty, and aromatherapeutic products. Its products include the provision of skin treatments, beauty and spa services, and skincare consulting and beauty training services. The company's spas provide various services, including hydrotherapy, facial treatment, body care, and skincare analysis. The company derived its key revenue from franchised spas, self-owned spas, and concessionary counters at department stores. Geographically it has three-segment which include The PRC, Taiwan, and Others (Hong Kong and Malaysia). Its key revenue is generated from PRC.

Executives

Tsai Yen-yu	2201 Interest of corporation controlled by you
Chao Shih-heng	2201 Interest of corporation controlled by you
Good Titanic Limited	2201 Interest of corporation controlled by you
Lee Ming-ta	2202 Interest of your spouse
Eastern Media International Corporation (twse Stock Code: 2614)	2201 Interest of corporation controlled by you
Next Focus Holdings Limited	2201 Interest of corporation controlled by you
Standard Cosmos Limited	2201 Interest of corporation controlled by you
Starsign International Limited	2201 Interest of corporation controlled by you

Natural Beauty Bio-Technology (HKSE:00157) Headlines

No Headlines